Open-Label Phase II Study of Olokizumab in Adolescent Patients with Polyarticular Juvenile Idiopathic Arthritis: Results of the 24-Week Treatment Period
- DOI
- 10.3390/ph19010079
- Published
- 2025-12-30
- Container
- Pharmaceuticals
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/ph19010079,
title = {Open-Label Phase II Study of Olokizumab in Adolescent Patients with Polyarticular Juvenile Idiopathic Arthritis: Results of the 24-Week Treatment Period},
author = {Ekaterina I. Alexeeva and Tatiana M. Dvoryakovskaya and Irina P. Nikishina and Elena S. Zholobova and Valeriya G. Matkava and Elizaveta A. Krekhova and Rinat K. Raupov and Daria V. Bukhanova and Alina N. Egorova and Sergey A. Grishin and Mikhail Yu. Samsonov and Mikhail M. Kostik},
year = {2025},
journal = {Pharmaceuticals},
doi = {10.3390/ph19010079},
url = {https://doi.org/10.3390/ph19010079}
}RIS
TY - JOUR TI - Open-Label Phase II Study of Olokizumab in Adolescent Patients with Polyarticular Juvenile Idiopathic Arthritis: Results of the 24-Week Treatment Period AU - Ekaterina I. Alexeeva AU - Tatiana M. Dvoryakovskaya AU - Irina P. Nikishina AU - Elena S. Zholobova AU - Valeriya G. Matkava AU - Elizaveta A. Krekhova AU - Rinat K. Raupov AU - Daria V. Bukhanova AU - Alina N. Egorova AU - Sergey A. Grishin AU - Mikhail Yu. Samsonov AU - Mikhail M. Kostik PY - 2025 JO - Pharmaceuticals DO - 10.3390/ph19010079 UR - https://doi.org/10.3390/ph19010079 ER -
APA
Alexeeva, E. I., Dvoryakovskaya, T. M., Nikishina, I. P., Zholobova, E. S., Matkava, V. G., Krekhova, E. A., Raupov, R. K., Bukhanova, D. V., Egorova, A. N., Grishin, S. A., Samsonov, M. Y., & Kostik, M. M. (2025). Open-Label Phase II Study of Olokizumab in Adolescent Patients with Polyarticular Juvenile Idiopathic Arthritis: Results of the 24-Week Treatment Period. Pharmaceuticals. https://doi.org/10.3390/ph19010079
Source records
- crossref · retrieved 2026-09-26T16:51:13.358Z